Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein cholesterol and, therefore, reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). Because FH patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Helen, Leung, Keith S. K., Garg, Tulika, Mazzoleni, Adele, Miteu, Goshen D., Zakariya, Farida, Awuah, Wireko A., Yin, Elaine T. S., Haroon, Faaraea, Hussain, Zarish, Aji, Narjiss, Jaiswal, Vikash, Tse, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436799/
https://www.ncbi.nlm.nih.gov/pubmed/37260143
http://dx.doi.org/10.1002/clc.24059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436799/
https://www.ncbi.nlm.nih.gov/pubmed/37260143
http://dx.doi.org/10.1002/clc.24059

Ejemplares similares